Expression of p53, c-erbB-2 and Cathepsin D in Relation to Hormone Receptors in Primary Breast Cancer

Authors

  • Supornpim Chearskul Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok
  • Kris Bhothisuwan Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Smarn Onreabroi Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok
  • Malika Churintrapun Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok
  • Namoiy Semprasert Department of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok

Keywords:

c-erbB-2, Cathepsin D, Hormone Receptors, Breast Cancer

Abstract

The immunohistochemical expression of p53, c-erbB-2, and cathepsin D oncogene proteins was examined in 494 primary breast carcinomas. This study aimed to investigate an association of expression of these three proteins with other variables known to be related to poor prognosis as well as with 5-year disease free survival (DFS). P53, c-erbB-2, and cathepsin D alone or in combination was negatively correlated with the presence of estrogen and progesterone receptors in breast cancer tissues. Alteration of these oncogenes rendering an expression of the proteins may affect the synthesis of steroid receptor proteins during the course of breast cancers. However, their significance as predictors of 5- year DFS was not achieved in this group of patients. Lymph node invasion was the only independent indicator for recurrent or metastatic breast carcinoma.

Downloads

Published

11-08-2020

How to Cite

Chearskul, S. ., Bhothisuwan, K. ., Onreabroi, S. ., Churintrapun, M. ., & Semprasert, N. . (2020). Expression of p53, c-erbB-2 and Cathepsin D in Relation to Hormone Receptors in Primary Breast Cancer. Siriraj Medical Journal, 53(4), 206–217. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/244107

Issue

Vol. 53 No. 4 (2001): April

Section

Original Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.